Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTXR | ZTS | TAK | UTHR | NBIX |
| Company | Citius Pharmaceuticals Inc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Neurocrine Bioscienc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
| Open | 0.7700 | 149.25 | 13.32 | 233.61 | 140.89 |
| High | 0.7701 | 151.46 | 13.33 | 240.13 | 144.70 |
| Low | 0.7200 | 148.75 | 13.22 | 233.28 | 139.12 |
| Last | 0.7210 | 151.71 | 13.23 | 239.78 | 139.27 |
| Change | -0.0463 | +2.15 | -0.15 | +5.31 | -0.82 |
| % Change | -6.03% | +1.44% | -1.12% | +2.26% | -0.59% |
| Volume | 235,008 | 1,107,940 | 238,679 | 102,096 | 218,859 |
| 20-Day Average Volume | 1,237,205 | 3,967,375 | 1,728,263 | 511,894 | 777,398 |
| Previous Close | 0.7673 | 149.56 | 13.38 | 234.47 | 140.09 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.8540 | 158.66 | 13.49 | 234.76 | 136.61 |
| 20-Day Raw Stochastic | 6.78% | 23.54% | 10.32% | 63.69% | 65.84% |
| 20-Day Relative Strength | 44.22% | 34.56% | 36.63% | 55.17% | 55.68% |
| Weighted Alpha | -44.49 | -19.96 | -20.58 | +6.58 | +40.97 |
| Today's Opinion | 24% Sell | 88% Sell | 100% Sell | 80% Buy | 96% Buy |
| Previous Opinion | 8% Buy | 88% Sell | 100% Sell | 64% Buy | 96% Buy |
| Last Month's Opinion | 8% Sell | 40% Sell | 72% Sell | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.16% since 04/17/24 | -0.62% since 04/17/24 | +0.68% since 04/17/24 | +1.76% since 04/17/24 | +5.02% since 04/17/24 |
| Low | 0.7000 on 04/22/24 | 144.80 on 04/22/24 | 13.12 on 04/18/24 | 233.27 on 04/24/24 | 130.13 on 04/19/24 |
| High | 1.0400 on 04/18/24 | 153.67 on 04/18/24 | 13.41 on 04/23/24 | 240.74 on 04/18/24 | 145.00 on 04/23/24 |
| 1-Month | |||||
| %Chg | -8.01% since 03/22/24 | -10.60% since 03/22/24 | -8.12% since 03/22/24 | +0.66% since 03/22/24 | -1.07% since 03/22/24 |
| Low | 0.7000 on 04/22/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 221.53 on 04/01/24 | 130.13 on 04/19/24 |
| High | 1.0700 on 04/02/24 | 171.14 on 03/28/24 | 14.45 on 03/26/24 | 250.89 on 03/26/24 | 145.00 on 04/23/24 |
| 3-Month | |||||
| %Chg | +13.28% since 01/24/24 | -18.85% since 01/24/24 | -9.81% since 01/24/24 | +9.44% since 01/24/24 | -0.14% since 01/24/24 |
| Low | 0.6000 on 02/08/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 128.00 on 02/07/24 |
| High | 1.0700 on 04/02/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 250.89 on 03/26/24 | 148.37 on 03/21/24 |
| 6-Month | |||||
| %Chg | -8.33% since 10/24/23 | -9.65% since 10/24/23 | -9.19% since 10/24/23 | +5.38% since 10/24/23 | +28.07% since 10/24/23 |
| Low | 0.6000 on 02/08/24 | 144.80 on 04/22/24 | 13.11 on 04/17/24 | 208.62 on 02/08/24 | 103.63 on 11/10/23 |
| High | 1.0700 on 04/02/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 258.31 on 12/14/23 | 148.37 on 03/21/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 122,074 | 68,402,608 | 42,345,264 | 11,033,921 | 13,939,936 |
| Shares Outstanding, K | 159,095 | 457,359 | 3,164,818 | 47,059 | 99,507 |
| Annual Sales | 0 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 1,887,100,000 |
| Annual Net Income | -32,540,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | 249,700,000 |
| Last Quarter Sales | 0 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 515,200,000 |
| Last Quarter Net Income | -9,230,000 | 525,000,000 | 718,900,000 | 217,100,000 | 147,700,000 |
| 60-Month Beta | 1.45 | 0.85 | 0.53 | 0.52 | 0.25 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/14/24 | 1.24 on 02/13/24 | 0.51 on 02/01/24 | 4.36 on 02/21/24 | 1.44 on 02/07/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/09/24 | 05/01/24 | 05/01/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.36 | 6.85 | 11.80 | 55.23 |